
#387: Diabetes Updates with Dr. Marie McDonnell: New Tools for the New Rules
The Curbsiders Internal Medicine Podcast
The Benefits of GLP1 Dual Agony
The company has realized that if you start low and go slow, you benefit the patient. The thing that we learned about the GIPG, GLP1 dual agonism is that for reasons that folks are still trying to figure out, it appears that GIP agonism kind of allows the GLP1 to do its thing with less GI side effects. So I like it and it works and patients love it. And the weight loss. We talk to this, it's 20 to 30% in a fair amount of the patients, which is insane. Oh, interesting. Maybe a little support around diet. Yeah. Probably you can get 20% if you can really hammer home some reduced
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.